MedTech pilot grant applications due May 1
MedTech pilot grant recipients receive design and business advice from Biodesign faculty and industry experts during their grant year.
Photo Courtesy of Biodesign
Stanford Center for Clinical and Translational Research and Education (Spectrum) annually awards up to $50,000 in pilot funding to interdisciplinary teams of students, clinicians and faculty with projects involving novel medical devices or mobile apps that treat or diagnose disease.
Participating teams receive mentoring from the Stanford Byers Center for Biodesign and industry experts, and they benefit from Biodesign’s time-tested innovation process for solving health-care problems. This Biodesign-Spectrum pilot grant program has awarded 46 project teams $1.5 million in seed funding, resulting in 23 startup companies since 2010.
In recent years, a few of the successful technologies funded through the Spectrum Medtech Pilot Grant program include:
- Oculeve (TrueTear): a neurostimulation device designed to treat dry eye
- Intact Therapeutics: a novel drug delivery system for ulcerative colitis patients
- Kōli: a device for treating gallstone disease without surgery
- palmm: a bioelectronic home therapy for excessive hand sweat
- Prescient Surgical (CleanCision): a wound retraction system that reduces surgical site infections
The Spectrum pilot grants are funded by a Clinical and Translational Science Award from the National Institutes of Health. Spectrum also awards pilot grants for predictive tools and diagnostics through the SPADA program, and for drugs and therapeutics through the SPARK program. Awardees are mentored throughout the year by teams of experts in each of these areas.
MedTech Pilot grant applications are due by 6:00 p.m. on May 1. The SPADA and SPARK grant application deadlines for 2020 will be announced later in the year.